Stefan Agewall
Norwegian version of this page
Username
Visiting address
Kirkeveien 166
Bygning 3
0450 Oslo
Postal address
Postboks 4956 Nydalen
OUS HF Ullevål sykehus
0424 Oslo
Publications
-
Xiong, Wei; Agewall, Stefan & Yamashita, Yugo (2024). Anticoagulation in cancer-associated thrombosis: how long should the therapy be? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 10(1), p. 3–4. doi: 10.1093/ehjcvp/pvad075.
-
Tjessem, Lars Holm & Agewall, Stefan (2023). EVALUATION OF A STRUCTURALIZED SICK-LEAVE PROGRAMME COMPARED WITH USUAL CARE SICK-LEAVE MANAGEMENT FOR PATIENTS AFTER AN ACUTE MYOCARDIAL INFARCTION. Journal of Rehabilitation Medicine. ISSN 1650-1977. 55. doi: 10.2340/jrm.v55.4569. Full text in Research Archive
-
Seekircher, Lisa; Tschiderer, Lena; Lind, Lars; Safarova, Maya S; Kavousi, Maryam & Ikram, M. Arfan [Show all 39 contributors for this article] (2023). Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment. European Heart Journal Open (EHJ Open). 3(5). doi: 10.1093/ehjopen/oead089. Full text in Research Archive
-
Berg, Emma; Agewall, Stefan; Brolin, Elin B.; Caidahl, Kenneth; Cederlund, Kerstin & Collste, Olov [Show all 16 contributors for this article] (2023). Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries. European Heart Journal - Quality of Care and Clinical Outcomes. ISSN 2058-5225. 9(6), p. 639–644. doi: 10.1093/ehjqcco/qcac072. Full text in Research Archive
-
Wärme, Jonatan; Sundqvist, Martin O.; Hjort, Marcus; Agewall, Stefan; Collste, Olov & Ekenbäck, Christina [Show all 16 contributors for this article] (2023). Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease. International Journal of Molecular Sciences. ISSN 1661-6596. 24(18). doi: 10.3390/ijms241814143. Full text in Research Archive
-
Drexel, Heinz; Tamargo, Juan; Kaski, Juan Carlos; Lewis, Basil S.; Saely, Christoph H. & Fraunberger, Peter [Show all 11 contributors for this article] (2023). Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(6), p. 570–582. doi: 10.1093/ehjcvp/pvad044.
-
Fröhlich, Hanna; Bossmeyer, Anna; Kazmi, Syed; Goode, Kevin M.; Agewall, Stefan & Atar, Dan [Show all 12 contributors for this article] (2023). Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus. Clinical Research in Cardiology. ISSN 1861-0684. doi: 10.1007/s00392-023-02268-3. Full text in Research Archive Show summary
-
Tschiderer, Lena; Seekircher, Lisa; Izzo, Raffaele; Mancusi, Costantino; Manzi, Maria V. & Baldassarre, Damiano [Show all 63 contributors for this article] (2023). Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies. Journal of the American Heart Association (JAHA). ISSN 2047-9980. 12(12). doi: 10.1161/JAHA.122.027657. Full text in Research Archive
-
Tamargo, Juan; Agewall, Stefan; Borghi, Claudio; Ceconi, Claudio; Cerbai, Elisabetta & Dan, Gheorghe A. [Show all 15 contributors for this article] (2023). New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(4), p. 353–370. doi: 10.1093/ehjcvp/pvad034.
-
Drexel, Heinz; Saely, Christoph H. & Agewall, Stefan (2023). Fibrates: one more lost paradise in lipid treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(2). doi: 10.1093/ehjcvp/pvac072.
-
Martínez-Montesinos, Lorena; Rivera-Caravaca, José Miguel; Agewall, Stefan; Soler, Eva; Lip, Gregory Y.H. & Marín, Francisco [Show all 7 contributors for this article] (2023). Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomedicine & Pharmacotherapy. ISSN 0753-3322. 158. doi: 10.1016/j.biopha.2022.114064. Full text in Research Archive
-
Nguyen, Thao; Fagerland, Morten; Hollan, Ivana; Whist, Jon Elling; Feinberg, Mark W. & Agewall, Stefan (2023). High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis. PLOS ONE. ISSN 1932-6203. 18:e0281155.(2), p. 1–10. doi: 10.1371/journal.pone.0281155. Full text in Research Archive Show summary
-
Komiyama, Maki; Agewall, Stefan & Hasegawa, Koji (2022). Future of antithrombotic therapy for heart failure with coronary artery disease. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. doi: 10.1093/ehjcvp/pvac030.
-
Hokstad, Ingrid; Greco, Daniela; Deyab, Gia; Fagerland, Morten; Agewall, Stefan & Hjeltnes, Gunnbjørg [Show all 10 contributors for this article] (2022). Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies. Journal of Clinical Medicine. ISSN 2077-0383. 11(24). doi: 10.3390/jcm11247330. Full text in Research Archive Show summary
-
Tamargo, Juan; Kaski, Juan Carlos; Kimura, Takeshi; Barton, Jack Charles; Yamamoto, Ko & Komiyama, Maki [Show all 10 contributors for this article] (2022). Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(7), p. 738–751. doi: 10.1093/ehjcvp/pvac040.
-
Drexel, Heinz; Pocock, Stuart J; Lewis, Basil S; Saely, Christoph H; Kaski, Juan Carlos & Rosano, Giuseppe M. C [Show all 19 contributors for this article] (2022). Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(3), p. 302–310. doi: 10.1093/ehjcvp/pvab048. Full text in Research Archive
-
Tamargo, Juan; Kjeldsen, Keld Per; Delpon, Eva; Semb, Anne Grete; Cerbai, Elisabetta & Dobrev, Dobromir [Show all 19 contributors for this article] (2022). Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(4), p. 406–419. doi: 10.1093/ehjcvp/pvac005.
-
El Hadidi, Seif; Rosano, Giuseppe; Tamargo, Juan; Agewall, Stefan; Drexel, Heinz & Kaski, Juan Carlos [Show all 10 contributors for this article] (2022). Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(2), p. 187–210. doi: 10.1093/ehjcvp/pvaa108.
-
Magavern, Emma F.; Kaski, Juan Carlos; Turner, Richard M.; Drexel, Heinz; Janmohamed, Azara & Scourfield, Andrew [Show all 21 contributors for this article] (2022). Challenges in cardiovascular pharmacogenomics implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(1), p. 100–103. doi: 10.1093/ehjcvp/pvab063.
-
Magavern, Emma Forton; Kaski, Juan Carlos; Turner, Richard M.; Drexel, Heinz; Janmohamed, Azara & Scourfield, Andrew [Show all 21 contributors for this article] (2022). The role of pharmacogenomics in contemporary cardiovascular therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(1), p. 85–99. doi: 10.1093/ehjcvp/pvab018.
-
Hall, Trygve Sørdahl; Ørn, Stein; Zannad, Faiez; Rossignol, Patrick; Duarte, Kevin & Solomon, Scott D. [Show all 10 contributors for this article] (2022). The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction. Journal of Women's Health. ISSN 1540-9996. 31(3), p. 310–320. doi: 10.1089/jwh.2021.0326.
-
Nguyen, Thao; Hokstad, Ingrid; Fagerland, Morten; Mollnes, Tom Eirik; Hollan, Ivana & Feinberg, Mark W. [Show all 10 contributors for this article] (2022). Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis. PLOS ONE. ISSN 1932-6203. 17 (2), p. 1–18. doi: 10.1371/journal.pone.0264628. Full text in Research Archive Show summary
-
Sörensson, Peder; Ekenbäck, Christina; Lundin, Magnus; Agewall, Stefan; Bacsovics Brolin, Elin & Caidahl, Kenneth [Show all 20 contributors for this article] (2021). Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries. JACC Cardiovascular Imaging. ISSN 1936-878X. 14(9), p. 1774–1783. doi: 10.1016/j.jcmg.2021.02.021. Full text in Research Archive
-
Tamargo, Juan & Agewall, Stefan (2021). Fluoroquinolone use and valvular heart disease: Is the jury still out? European Heart Journal. ISSN 0195-668X. 42(30), p. 2909–2911. doi: 10.1093/eurheartj/ehab426.
-
Drexel, Heinz; Lewis, Basil S.; Rosano, Giuseppe M. C.; Saely, Christoph H.; Tautermann, Gerda & Huber, Kurt [Show all 18 contributors for this article] (2021). The age of randomized clinical trials: Three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(5), p. 453–459. doi: 10.1093/ehjcvp/pvaa126.
-
Deyab, Gia; Reine, Trine M.; Vuong, Tram Thu; Jenssen, Trond Geir; Hjeltnes, Gunnbjørg & Agewall, Stefan [Show all 11 contributors for this article] (2021). Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis. PLOS ONE. ISSN 1932-6203. 16(7). doi: 10.1371/journal.pone.0253247. Full text in Research Archive Show summary
-
Svenungsson, Elisabet; Spaak, Jonas; Strandberg, Karin; Wallén, Håkan N.; Agewall, Stefan & Brolin, Elin B. [Show all 17 contributors for this article] (2021). Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries. Journal of Internal Medicine. ISSN 0954-6820. doi: 10.1111/joim.13409. Full text in Research Archive
-
Krogager, Maria Lukács; Kragholm, Kristian; Thomassen, Jesper Qvist; Søgaard, Peter; Lewis, Basil S & Wassmann, Sven [Show all 19 contributors for this article] (2021). Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(6), p. 557–567. doi: 10.1093/ehjcvp/pvab038.
-
Nguyen, Thao; Fagerland, Morten; Deyab, Gia; Hjeltnes, Gunnbjørg; Hollan, Ivana & Feinberg, Mark W. [Show all 9 contributors for this article] (2021). Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis. PLOS ONE. ISSN 1932-6203. 16:e0253793(6), p. 1–17. doi: 10.1371/journal.pone.0253793. Full text in Research Archive Show summary
-
Täger, Tobias; Frankenstein, Lutz; Atar, Dan; Agewall, Stefan; Frey, Norbert & Grundtvig, Morten [Show all 9 contributors for this article] (2021). Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical Research in Cardiology. ISSN 1861-0684. doi: 10.1007/s00392-021-01913-z. Full text in Research Archive Show summary
-
Y-Hassan, Shams; Sörensson, Peder; Ekenbäck, Christina; Lundin, Magnus; Agewall, Stefan & Brolin, Elin Bacsovics [Show all 20 contributors for this article] (2021). Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study. Clinical Cardiology. ISSN 0160-9289. doi: 10.1002/clc.23723. Full text in Research Archive
-
Tschiderer, Lena; Seekircher, Lisa; Klingenschmid, Gerhard; Izzo, Raffaele; Baldassarre, Damiano & Iglseder, Bernhard [Show all 63 contributors for this article] (2020). The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale. Gerontology. ISSN 0304-324X. 66(5), p. 447–459. doi: 10.1159/000508498.
-
Lewis, Basil S.; Agewall, Stefan & Rosano, Giuseppe (2020). MSc in clinical trials: a new flagship Working Group project. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(5). doi: 10.1093/ehjcvp/pvaa078.
-
Willeit, Peter; Tschiderer, Lena; Allara, Elias; Reuber, Kathrin; Seekircher, Lisa & Gao, Lu [Show all 76 contributors for this article] (2020). Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk : Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Circulation. ISSN 0009-7322. 142(7), p. 621–642. doi: 10.1161/CIRCULATIONAHA.120.046361. Show summary
-
Drexel, Heinz; Rosano, Giuseppe; Lewis, Basil S.; Huber, Kurt; Vonbank, Alexander & Dopheide, Jörn F [Show all 11 contributors for this article] (2020). The age of randomized clinical trials: Three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2), p. 97–103. doi: 10.1093/ehjcvp/pvz029. Full text in Research Archive
-
Täger, Tobias; Atar, Dan; Agewall, Stefan; Katus, Hugo A.; Grundtvig, Morten & Cleland, John G.F. [Show all 9 contributors for this article] (2020). Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Failure Reviews. ISSN 1382-4147. p. 1–15. doi: 10.1007/s10741-020-09954-8. Full text in Research Archive Show summary
-
Knuuti, Juhani; Wijns, William; Saraste, Antti; Capodanno, Davide; Barbato, Emanuele & Funck-Brentano, Christian [Show all 25 contributors for this article] (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. ISSN 0195-668X. 41(3), p. 407–477. doi: 10.1093/eurheartj/ehz425.
-
Savarese, Gianluigi; Reiner, Martin F; Uijl, Alicia; D'Amario, Domenico; Agewall, Stefan & Atar, Dan [Show all 23 contributors for this article] (2020). Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2), p. 86–93. doi: 10.1093/ehjcvp/pvz036. Full text in Research Archive
-
Bahls, Martin; Lorenz, Matthias W.; Dörr, Marcus; Gao, Lu; Kitagawa, Kazuo & Tuomainen, Tomi-Pekka [Show all 55 contributors for this article] (2020). Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium. European Journal of Preventive Cardiology (EJPC). ISSN 2047-4873. 27(3), p. 234–243. doi: 10.1177/2047487319877078. Full text in Research Archive
-
Rosano, Giuseppe M.C.; Spoletini, Ilaria; Vitale, Cristina & Agewall, Stefan (2019). Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction. Cardiac failure review. ISSN 2057-7540. 5(3), p. 130–132. doi: 10.15420/cfr.2019.8.2. Full text in Research Archive
-
Hollan, Ivana; Ronda, Nicoletta; Dessein, Patrick; Agewall, Stefan; Karpouzas, George & Tamargo, Juan [Show all 12 contributors for this article] (2019). Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2), p. 104–114. doi: 10.1093/ehjcvp/pvz033.
-
von Lueder, Thomas Gero; Atar, Dan; Agewall, Stefan; Jensen, Jesper K; Hopper, Ingrid & Kotecha, Dipak [Show all 9 contributors for this article] (2019). All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System . American Journal of Therapeutics. ISSN 1075-2765. 26(6), p. e671–e678. doi: 10.1097/MJT.0000000000000883. Full text in Research Archive
-
Hjort, Marcus; Eggers, Kai M.; Lindhagen, Lars; Agewall, Stefan; Brolin, Elin B. & Collste, Olov [Show all 17 contributors for this article] (2019). Increased inflammatory activity in patients 3 months after myocardial infarction with nonobstructive coronary arteries. Clinical Chemistry. ISSN 0009-9147. 65(8), p. 1023–1030. doi: 10.1373/clinchem.2018.301085.
-
Hall, Trygve Sørdahl; von Lueder, Thomas Gero; Zannad, Faïez; Rossignol, Patrick; Duarte, Kévin & Chouihed, Tahar [Show all 11 contributors for this article] (2019). Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. American Heart Journal. ISSN 0002-8703. 215, p. 83–90. doi: 10.1016/j.ahj.2019.06.004. Full text in Research Archive
-
Hokstad, Ingrid; Deyab, Gia; Fagerland, Morten; Lyberg, Torstein; Hjeltnes, Gunnbjørg & Førre, Øystein Thorleiv [Show all 9 contributors for this article] (2019). Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study. PLOS ONE. ISSN 1932-6203. 14(7), p. 1–16. doi: 10.1371/journal.pone.0220079. Full text in Research Archive Show summary
-
Sulzgruber, Patrick; Wassmann, Sven; Semb, Anne Grete; Doehner, Wolfram; Widimský, Petr & Gremmel, Thomas [Show all 19 contributors for this article] (2019). Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(3), p. 171–180. doi: 10.1093/ehjcvp/pvz016. Full text in Research Archive
-
Rosano, Giuseppe M.C.; Spoletini, Ilaria & Agewall, Stefan (2019). Pharmacology of new treatments for hyperkalaemia: Patiromer and sodium zirconium cyclosilicate. European Heart Journal, Supplement. ISSN 1520-765X. 21, p. A28–A33. doi: 10.1093/eurheartj/suy035. Full text in Research Archive
-
Hausvater, Anais; Pasupathy, Sivabaskari; Tornvall, Per; Gandhi, Himali; Tavella, Rosanna & Beltrame, John [Show all 12 contributors for this article] (2019). ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries. International Journal of Cardiology. ISSN 0167-5273. 287, p. 128–131. doi: 10.1016/j.ijcard.2019.04.028.
-
Täger, Tobias; Fröhlich, Hanna; Grundtvig, Morten; Seiz, Mirjam; Schellberg, Dieter & Goode, Kevin [Show all 14 contributors for this article] (2019). Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure – A multicenter propensity score matched analysis. International Journal of Cardiology. ISSN 0167-5273. 289, p. 83–90. doi: 10.1016/j.ijcard.2019.01.109. Full text in Research Archive Show summary
-
Navarese, Eliano Pio; Andreotti, Felicita; Raggi, Paolo; Kolodziejczak, Michalina; Buffon, Antonino & Bliden, Kevin [Show all 13 contributors for this article] (2019). Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(1), p. 47–54. doi: 10.1093/ehjcvp/pvy038. Full text in Research Archive
-
Fröhlich, Hanna; Rosenfeld, Nitzan; Täger, Tobias; Goode, Kevin; Kazmi, Syed & Hole, Torstein [Show all 13 contributors for this article] (2019). Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart. ISSN 1355-6037. 105(16), p. 1252–1259. doi: 10.1136/heartjnl-2018-314256.
-
Nero, Daniella; Agewall, Stefan; Daniel, Maria; Caidahl, Kenneth; Collste, Olov & Ekenbäck, Christina [Show all 17 contributors for this article] (2018). Personality traits in patients with myocardial infarction with nonobstructive coronary arteries. American Journal of Medicine. ISSN 0002-9343. 132(3), p. 374–381.e1. doi: 10.1016/j.amjmed.2018.11.010.
-
Vonbank, Alexander; Drexel, Heinz; Agewall, Stefan; Lewis, Basil S.; Dopheide, Jörn Fredrik & Kjeldsen, Keld [Show all 15 contributors for this article] (2018). Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(4), p. 230–236. doi: 10.1093/ehjcvp/pvy028.
-
Daniel, Maria; Agewall, Stefan; Berglund, Felix; Caidahl, Kenneth; Collste, Olov & Ekenbäck, Christina [Show all 17 contributors for this article] (2018). Prevalence of anxiety and depression symptoms in patients with myocardial infarction with non-obstructive coronary arteries. American Journal of Medicine. ISSN 0002-9343. 131(9), p. 1118–1124. doi: 10.1016/j.amjmed.2018.04.040.
-
Serebruany, Victor L.; Hall, Trygve Sørdahl; Atar, Dan; Agewall, Stefan; Kim, Moo Hyun & Geudelin, Bernhard [Show all 8 contributors for this article] (2018). Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System. Journal of Cardiovascular Pharmacology. ISSN 0160-2446. 5(4), p. 210–215. doi: 10.1093/ehjcvp/pvy035.
-
Hall, Trygve Sørdahl; von Lueder, Thomas Gero; Zannad, Faiez; Rossignol, Patrick; Duarte, Kevin & Chouihed, Tahar [Show all 10 contributors for this article] (2018). Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. International Journal of Cardiology. ISSN 0167-5273. 272, p. 260–266. doi: 10.1016/j.ijcard.2018.07.137.
-
Rosano, Giuseppe M.C.; Tamargo, Juan; Kjeldsen, Keld P.; Lainscak, Mitja; Agewall, Stefan & Anker, Stefan D. [Show all 20 contributors for this article] (2018). Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(3), p. 180–188. doi: 10.1093/ehjcvp/pvy015.
-
Niessner, Alexander; Tamargo, Juan; Koller, Lorenz; Saely, Christoph H.; Schmidt, Thomas Andersen & Savarese, Gianluigi [Show all 16 contributors for this article] (2018). Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal. ISSN 0195-668X. 39(24), p. 2274–2281. doi: 10.1093/eurheartj/ehx625.
-
Agewall, Stefan (2023). Cardiovascular preventive actions. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(6), p. 497–498. doi: 10.1093/ehjcvp/pvad054.
-
Agewall, Stefan (2023). Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(5), p. 401–402. doi: 10.1093/ehjcvp/pvad049.
-
Agewall, Stefan (2023). Focus on prevention in diabetes mellitus and lipid disorder. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(4), p. 295–296. doi: 10.1093/ehjcvp/pvad037.
-
Agewall, Stefan (2023). A tailor-made suit always fits best. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(3), p. 199–200. doi: 10.1093/ehjcvp/pvad024.
-
Agewall, Stefan (2023). Focus on lipid treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(2), p. 119–120. doi: 10.1093/ehjcvp/pvad007.
-
Aunan, Kristin; Atar, Dan & Agewall, Stefan (2023). Klima - en hjertesak. Hjerteforum. ISSN 0802-1465. 1, p. 54–61.
-
Agewall, Stefan (2022). Pharmacological treatment of CVD. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 9(1), p. 1–3. doi: 10.1093/ehjcvp/pvac068.
-
Tamargo, Juan; Hasegawa, Koji & Agewall, Stefan (2022). Toward personalized medicine for cardiovascular pharmacotherapy. European Heart Journal. ISSN 0195-668X. 43(45), p. 4719–4721. doi: 10.1093/eurheartj/ehac413.
-
Agewall, Stefan (2022). Future of European Heart Journal Cardiovascular Pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(8). doi: 10.1093/ehjcvp/pvac061.
-
Agewall, Stefan (2022). To treat or not to treat. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(8), p. 754–755. doi: 10.1093/ehjcvp/pvac062.
-
Agewall, Stefan (2022). Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(7), p. 645–647. doi: 10.1093/ehjcvp/pvac048.
-
Agewall, Stefan (2022). Prevention is still the key to success. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(6), p. 537–538. doi: 10.1093/ehjcvp/pvac046.
-
Agewall, Stefan (2022). Focus on optimizing treatment of coronary heart disease. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(5), p. 431–433. doi: 10.1093/ehjcvp/pvac039.
-
Agewall, Stefan (2022). New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(3), p. 213–215. doi: 10.1093/ehjcvp/pvac019.
-
Agewall, Stefan (2022). Focus on different aspects of atrial fibrillation. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(4), p. 323–324. doi: 10.1093/ehjcvp/pvac035.
-
Agewall, Stefan (2022). Optimizing individual heart failure treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(2), p. 105–107. doi: 10.1093/ehjcvp/pvab087.
-
Agewall, Stefan (2022). Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 8(1), p. 1–3. doi: 10.1093/ehjcvp/pvab078.
-
Agewall, Stefan (2021). Different aspects of giving the optimal antiplatelet treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(3), p. 169–170. doi: 10.1093/ehjcvp/pvab037.
-
Agewall, Stefan (2021). Adherence to pharmacological treatment: How can we improve? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(4), p. 261–262. doi: 10.1093/ehjcvp/pvab049.
-
Agewall, Stefan (2021). Antiplatelet treatment in coronary syndrome. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(2), p. 81–82. doi: 10.1093/ehjcvp/pvab015.
-
Agewall, Stefan (2021). Unsolved pharmacological issues with cardiology. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(6), p. 461–462. doi: 10.1093/ehjcvp/pvab077.
-
Agewall, Stefan (2021). More knowledge about atrial fibrillation, still we need to learn. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(5), p. 361–362. doi: 10.1093/ehjcvp/pvab067.
-
Agewall, Stefan (2021). Atrial fibrillation in registries. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 7(1), p. 1–2. doi: 10.1093/ehjcvp/pvaa142.
-
Agewall, Stefan (2020). Focus on blood pressure and risk factor intervention. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(6), p. 339–340. doi: 10.1093/ehjcvp/pvaa130.
-
Agewall, Stefan (2020). Focus on subpopulations of atrial fibrillation patients. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(3), p. 131–132. doi: 10.1093/ehjcvp/pvaa034.
-
Agewall, Stefan (2020). Lipids and antithrombotic treatment. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(2). doi: 10.1093/ehjcvp/pvaa014.
-
Agewall, Stefan (2020). Focus on pharma in acute coronary syndrome. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(1), p. 1–2. doi: 10.1093/ehjcvp/pvz074.
-
Agewall, Stefan (2020). Minimizing bleeding events. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(5), p. 271–272. doi: 10.1093/ehjcvp/pvaa100.
-
Hall, Trygve Sørdahl; Orn, S; Zanned, F.; Rossignol, Patrick; Duarte, K. & Solomon, S. [Show all 10 contributors for this article] (2020). The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction .
-
Agewall, Stefan (2020). Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome? European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 6(4), p. 201–202. doi: 10.1093/ehjcvp/pvaa075.
-
Agewall, Stefan (2019). European Heart Journal - Cardiovascular Pharmacotherapy: Now accepted for an official Impact Factor. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2). doi: 10.1093/ehjcvp/pvz009.
-
Agewall, Stefan (2019). Antiplatelet treatment in acute coronary syndrome. Still an issue. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(3), p. 125–126. doi: 10.1093/ehjcvp/pvz018.
-
Agewall, Stefan (2019). European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(4), p. 183–184. doi: 10.1093/ehjcvp/pvz041.
-
Agewall, Stefan (2019). Unsolved issues in oral anticoagulation treatment in atrial fibrillation. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2), p. 60–61. doi: 10.1093/ehjcvp/pvz008.
-
Marciniak, Thomas A.; Hall, Trygve Sørdahl; Atar, Dan; Agewall, Stefan & Serebruany, Victor L. (2019). Ivabradine for heart failure: Regulatory differences in Europe and United States. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2), p. 119–121. doi: 10.1093/ehjcvp/pvz006.
-
Agewall, Stefan (2019). Old and new drugs in cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(1), p. 1–2. doi: 10.1093/ehjcvp/pvy046.
-
Agewall, Stefan (2018). New input on antiplatelet treatment and registry studies. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(3), p. 129–130. doi: 10.1093/ehjcvp/pvy016.
-
Agewall, Stefan (2018). Cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(1). doi: 10.1093/ehjcvp/pvx036.
-
Niessner, Alexander & Agewall, Stefan (2018). Critical appraisal of the COMPASS trial. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(4), p. 191–192. doi: 10.1093/ehjcvp/pvy027.
-
von Lueder, Thomas Gero & Agewall, Stefan (2018). The burden of heart failure in the general population: A clearer and more concerning picture. Journal of Thoracic Disease (JTD). ISSN 2072-1439. 10, p. S1934–S1937. doi: 10.21037/jtd.2018.04.153.
-
Agewall, Stefan (2018). Adherence to guidelines, compliance to treatment, and treatment quality. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(4), p. 189–190. doi: 10.1093/ehjcvp/pvy033.
-
Agewall, Stefan (2018). Cardiovascular pharmacotherapy and real-world data. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 4(2), p. 65–66. doi: 10.1093/ehjcvp/pvy008.
Published
Dec. 12, 2011 11:46 AM
- Last modified
June 7, 2016 11:17 AM